Literature DB >> 27062938

Comparison of Outcome of Patients With ST-Segment Elevation Myocardial Infarction and Complete Versus Incomplete ST-Resolution Before Primary Percutaneous Coronary Intervention.

Jacob Lønborg1, Henning Kelbæk2, Lene Holmvang3, Steffen Helqvist3, Niels Vejlstrup3, Erik Jørgensen3, Kari Saunamäki3, Nadia P Dridi3, Lene Kløvgaard3, Anne Kaltoft4, Hans-Erik Bøtker4, Jens F Lassen3, Peter Clemmensen3, Christian Juhl Terkelsen4, Thomas Engstrøm3.   

Abstract

Some patients presenting with ST-segment elevation myocardial infarction (STEMI) have complete ST resolution in the electrocardiogram, which may be clinical useful in the triage of patients with STEMI. However, the importance of complete ST resolution in these patients remains uncertain. Thus, the purpose was to describe the prognosis of patients with complete ST resolution before primary percutaneous coronary intervention (PCI). Continuous ST monitoring from arrival until 90 minutes after PCI was performed in 933 patients with STEMI. Complete ST resolution was defined as no residual significant ST elevations before intervention. The patients were followed clinically for 5.5 years (range 0 to 6.8 years). Infarct size and myocardial salvage were assessed in a subgroup of patients (n = 221) by cardiovascular magnetic resonance. Complete ST resolution was observed in 24% of the patients, who had a higher incidence of Thrombolysis In Myocardial Infarction grade 2/3 flow before intervention (64% vs 24%), smaller infarct size (6% vs 11%), and higher myocardial salvage index (0.82 vs 0.69; all p <0.001) compared with patients with continuous ST elevations. Complete ST resolution was associated with a significantly lower rate of the composite end point of all-cause death and admission for heart failure (14% vs 22%; p = 0.006) although it only tended to be an independent predictor in a multivariate analysis (hazard ratio 0.69, 95% CI 0.49 to 1.06; p = 0.09). In conclusion, compared to patients without incomplete ST resolution, patients with STEMI and complete ST resolution before primary PCI have a higher incidence of normalized epicardial flow before PCI, a larger myocardial salvage and smaller infarct size after the procedure and presumably improved long-term outcome compared with incomplete ST resolution.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27062938     DOI: 10.1016/j.amjcard.2016.03.009

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  4 in total

1.  Primary percutaneous coronary intervention is appropriate in transient ST-elevation myocardial infarction.

Authors:  Lumir Koc; Monika Mikolaskova; Tomas Novotny; Jiri Parenica; Jan Kanovsky; Tomas Ondrus; Maria Holicka; Martin Poloczek; Jiri Jarkovsky; Marek Malik; Petr Kala
Journal:  Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub       Date:  2021-02-04       Impact factor: 1.245

Review 2.  Importance of Endogenous Fibrinolysis in Platelet Thrombus Formation.

Authors:  Ying X Gue; Diana A Gorog
Journal:  Int J Mol Sci       Date:  2017-08-25       Impact factor: 5.923

3.  Tpeak-Tend/QT interval predicts ST-segment resolution and major adverse cardiac events in acute ST-segment elevation myocardial infarction patients undergoing percutaneous coronary intervention.

Authors:  Xianpei Wang; Lu Zhang; Chuanyu Gao; Jialu Zhu; Xiaohang Yang
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

4.  Left ventricular function, strain, and infarct characteristics in patients with transient ST-segment elevation myocardial infarction compared to ST-segment and non-ST-segment elevation myocardial infarctions.

Authors:  Ahmet Demirkiran; Nina W van der Hoeven; Gladys N Janssens; Jorrit S Lemkes; Henk Everaars; Peter M van de Ven; Nikki van Pouderoijen; Yvonne J M van Cauteren; Maarten A H van Leeuwen; Alexander Nap; Paul F Teunissen; Luuk H G A Hopman; Sebastiaan C A M Bekkers; Martijn W Smulders; Niels van Royen; Albert C van Rossum; Lourens F H J Robbers; Robin Nijveldt
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2022-06-01       Impact factor: 9.130

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.